Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) FCF Payout Ratio (2017 - 2025)

Fortress Biotech has reported FCF Payout Ratio over the past 9 years, most recently at 0.04 for Q4 2025.

  • Quarterly results put FCF Payout Ratio at 0.04 for Q4 2025, down 84.58% from a year ago — trailing twelve months through Sep 2025 was 0.04 (up 243.21% YoY), and the annual figure for FY2024 was 0.01, down 50.85%.
  • FCF Payout Ratio for Q4 2025 was 0.04 at Fortress Biotech, up from 0.03 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for FBIO hit a ceiling of 0.26 in Q4 2024 and a floor of 0.2 in Q3 2024.
  • Median FCF Payout Ratio over the past 5 years was 0.01 (2021), compared with a mean of 0.01.
  • Biggest five-year swings in FCF Payout Ratio: skyrocketed 3997.83% in 2023 and later plummeted 1738.68% in 2024.
  • Fortress Biotech's FCF Payout Ratio stood at 0.01 in 2021, then grew by 22.48% to 0.0 in 2022, then skyrocketed by 3997.83% to 0.15 in 2023, then surged by 70.17% to 0.26 in 2024, then crashed by 84.58% to 0.04 in 2025.
  • The last three reported values for FCF Payout Ratio were 0.04 (Q4 2025), 0.03 (Q3 2025), and 0.01 (Q2 2025) per Business Quant data.